K
Pharmaceuticals
Pharmaceuticals
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
Key Metrics | This Stock | Category (Avg) |
PE Ratio | 15.19 | 46.84 |
PB Ratio | 1.58 | 5.96 |
Dividend Yield | 1.87% | 0.56% |
Understand what these metrics mean.
For peer comparison & financials,
K
Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare.